InMed Pharmaceuticals (INM) Work In Process (2022 - 2025)
InMed Pharmaceuticals (INM) reported Work In Process of $569262.0 for Q4 2025, up 122.37% on a YoY basis from $255992.0 in Q4 2024, and up 34.64% quarter-over-quarter from $422798.0 in Q3 2025.
InMed Pharmaceuticals (INM) Work In Process (2022 - 2025) Analysis & Trends
InMed Pharmaceuticals has reported Work In Process for 4 years, with the latest figure at $569262.0 in Q4 2025.
- For the quarter ending Q4 2025, Work In Process rose 122.37% year-over-year to $569262.0; the trailing twelve-month figure through Dec 2025 stood at $569262.0 (up 122.37% YoY), and the FY2025 full-year result was $26695.0, down 13.38% from the prior year.
- Work In Process for Q4 2025 stood at $569262.0, up from $422798.0 in the prior quarter.
- The five-year high for Work In Process was $1.7 million in Q2 2022, with the low at $18446.0 in Q3 2024.
- Historically, Work In Process has averaged $424701.1 across 4 years, with a median of $373256.0 in 2025.
- Annual changes were most pronounced in 2024 — Work In Process sank 94.01% — and 2025, when it surged 2192.09%.
- InMed Pharmaceuticals' Work In Process stood at $798813.0 in 2022, then sank by 76.59% to $186980.0 in 2023, then surged by 36.91% to $255992.0 in 2024, then surged by 122.37% to $569262.0 in 2025.
- The last three Work In Process figures came in at $569262.0 (Q4 2025), $422798.0 (Q3 2025), and $26695.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | InMed Pharmaceuticals | 6.00 Mn | 756,271.05 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 569,262.00 |
| Sep 30, 2025 | 422,798.00 |
| Jun 30, 2025 | 26,695.00 |
| Mar 31, 2025 | 323,714.00 |
| Dec 31, 2024 | 255,992.00 |
| Sep 30, 2024 | 18,446.00 |
| Jun 30, 2024 | 30,817.00 |
| Mar 31, 2024 | 439,086.00 |
| Dec 31, 2023 | 186,980.00 |
| Sep 30, 2023 | 85,655.00 |
| Jun 30, 2023 | 514,113.00 |
| Mar 31, 2023 | 548,593.00 |
| Dec 31, 2022 | 798,813.00 |
| Jun 30, 2022 | 1.72 Mn |